Activating transcription factor 3 and cancer progression

  • Williams, Bryan (Primary Chief Investigator (PCI))
  • Hannigan, Greg, (Chief Investigator (CI))
  • Williams, Elizabeth, (Chief Investigator (CI))
  • Xu, Dakang (Chief Investigator (CI))

Project: Research

StatusFinished
Effective start/end date1/01/14 → 31/12/17

Funding

  • National Health & Medical Research Council (NHMRC): AUD737,110.00
View all
View less

Related content

Research Output

BTB-ZF transcriptional regulator PLZF modifies chromatin to restrain inflammatory signaling programs

Research output: Contribution to journal › Article › Research › peer-review

Overexpression of the transcription factor ATF3 with a regulatory molecular signature associates with the pathogenic development of colorectal cancer

Research output: Contribution to journal › Article › Research › peer-review

ATF3 repression of BCL-XL determines apoptotic sensitivity to HDAC inhibitors across tumor types

Research output: Contribution to journal › Article › Research › peer-review

Activating transcription factor 3 expression as a marker of response to the histone deacetylase inhibitor pracinostat

Research output: Contribution to journal › Article › Research › peer-review